Home › Companies › ADAPTIMMUNE THERAPEUTICS PLC › 2023-2024
At ADAPTIMMUNE THERAPEUTICS PLC's shareholder meeting held May 14, 2024, in the 2023-2024 proxy season, 68 asset managers reported how they voted on 14 ballot items in their SEC Form N-PX filings, covering 291 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ADAPTIMMUNE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 14, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ADAPTIMMUNE THERAPEUTICS PLC’s Form 8-K, filed May 14, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 14, 2024: 14 items on ADAPTIMMUNE THERAPEUTICS PLC’s Form 8-K, filed May 14, 2024: 14 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore ADAPTIMMUNE THERAPEUTICS PLC in the interactive database Compare manager voting policies
These tallies are ADAPTIMMUNE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Ordinary Resolution to re-elect Mr. David Mott as a Director | 996,265,374 | 40,033,364 | 4,026,750 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to re -elect Dr. Andrew Allen as a Director | 997,592,808 | 39,180,614 | 3,552,066 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to re -elect Mr. Lawrence Alleva as a Director | 998,026,824 | 40,221,146 | 2,077,518 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to re -elect Dr. Priti Hegde as a Director | 996,894,810 | 38,855,042 | 4,575,636 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to re -elect Dr. Kristen Hege as a Director | 998,463,018 | 37,328,846 | 4,533,624 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to re -elect Dr. Garry Menzel as a Director | 995,168,664 | 41,588,342 | 3,568,482 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to re-appoint KPMG LLP as auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders | 1,035,848,288 | 1,779,828 | 2,697,372 | -- | 470,003,532 | 99.8% | Not verified | — |
| Ordinary Resolution to authorize the Audit Committee to determine the Company's auditors' remuneration for the fiscal year ending December 31, 2024 | 1,032,924,716 | 4,547,610 | 2,853,162 | -- | 470,003,532 | 99.5% | Not verified | — |
| Ordinary Resolution to receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2023 and to note that the Directors do not recommend the payment of any dividend for the year ended December 31, 2023 | 1,035,201,062 | 3,157,752 | 1,966,674 | -- | 470,003,532 | 99.6% | Not verified | — |
| Ordinary Resolution to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2023 | 986,885,460 | 52,365,878 | 1,074,150 | -- | 470,003,532 | 95% | Not verified | — |
| Ordinary Resolution to receive and approve the Company's U.K. statutory Directors' remuneration report for the year ended December 31, 2023 | 995,699,310 | 43,710,950 | 915,228 | -- | 470,003,532 | 96% | Not verified | — |
| Ordinary Resolution to receive and approve the Company's Directors' remuneration policy, which if approved, will take effect upon conclusion of the Annual General Meeting | 987,953,508 | 50,684,876 | 1,687,104 | -- | 470,003,532 | 95% | Not verified | — |
| Ordinary Resolution to a uthorize the Directors, in accordance with section 551 of the U.K. Companies Act 2006 (the "2006 Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares | 1,003,344,206 | 34,985,646 | 1,995,636 | -- | 470,003,532 | 97% | Not verified | — |
| Special Resolution to empower the Directors to allot equity securities for cash pursuant to section 570(1) of the 2006 Act as if section 561(1) of the 2006 Act did not apply to such allotment | 1,001,822,888 | 36,443,448 | 2,059,152 | -- | 470,003,532 | 96% | Not verified | — |
Source: ADAPTIMMUNE THERAPEUTICS PLC, Form 8-K, filed with the SEC on May 14, 2024 — read the filing on EDGAR.
Each item below shows how the 68 asset managers that disclosed a ADAPTIMMUNE THERAPEUTICS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director, Andrew Allen, who retires in accordance with the Articles of Association.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 2 – Ordinary Resolution to re -elect Dr. Andrew Allen as a Director:”): 997,592,808 for, 39,180,614 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director, David Mott, who retires by rotation in accordance with the Articles of Association.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 1 – Ordinary Resolution to re-elect Mr. David Mott as a Director:”): 996,265,374 for, 40,033,364 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,896,598 for, 60,749 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 0 | 39,929 | 0 | 0 | Against |
| Northern Trust | 0 | 20,820 | 0 | 0 | Against |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director, Garry Menzel, who retires in accordance with the Articles of Association.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 6 – Ordinary Resolution to re -elect Dr. Garry Menzel as a Director:”): 995,168,664 for, 41,588,342 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,624,839 for, 332,508 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 137,870 | 0 | 0 | Against |
| HARBOR FUNDS | 0 | 135,565 | 0 | 0 | Against |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 0 | 59,073 | 0 | 0 | Against |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director, Kristen Hege, who retires in accordance with the Articles of Association.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 5 – Ordinary Resolution to re -elect Dr. Kristen Hege as a Director:”): 998,463,018 for, 37,328,846 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director, Lawrence Alleva, who retires by rotation in accordance with the Articles of Association.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 3 – Ordinary Resolution to re -elect Mr. Lawrence Alleva as a Director:”): 998,026,824 for, 40,221,146 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director, Priti Hegde, who retires in accordance with the Articles of Association.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 4 – Ordinary Resolution to re -elect Dr. Priti Hegde as a Director:”): 996,894,810 for, 38,855,042 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To authorize the Directors under Section 551 of the U.K. Companies Act 2006 (the "2006 Act") to allot shares or to grant rights to subscribe for or to convert any security into shares.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 13 – Ordinary Resolution to a uthorize the Directors, in accordance with section 551 of the U.K. Companies Act 2006 (the "2006 Act"), to allot shares in the Company or grant rights to subscribe for or to conve”): 1,003,344,206 for, 34,985,646 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 450,790 for, 1,506,557 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 0 | 1,485,464 | 0 | 0 | Against |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 20,820 | 0 | 0 | Against |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 273 | 0 | 0 | Against |
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To empower the Directors to allot equity securities for cash pursuant to Section 570(1) of the 2006 Act as if Section 561(1) of the 2006 Act did not apply to that allotment.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 14 – Special Resolution to empower the Directors to allot equity securities for cash pursuant to section 570(1) of the 2006 Act as if section 561(1) of the 2006 Act did not apply to such allotment:”): 1,001,822,888 for, 36,443,448 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 408,452 for, 1,548,895 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 0 | 1,485,464 | 0 | 0 | Against |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 66,702 | 2,409 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 0 | 39,929 | 0 | 0 | Against |
| Northern Trust | 0 | 20,820 | 0 | 0 | Against |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 273 | 0 | 0 | Against |
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2023 and to note that the Directors do not recommend the payment of any dividend for the year ended December 31, 2023.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 9 – Ordinary Resolution to receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2023 and to note that the Directors do not recommend the payment of any dividend for the”): 1,035,201,062 for, 3,157,752 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 10 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2023.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 10 – Ordinary Resolution to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2023:”): 986,885,460 for, 52,365,878 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 137,870 | 0 | 0 | Against |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Fund voting reports, all 10 managers: 1,819,477 for, 137,870 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 31,124,749 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 27,404,070 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 12,419,434 | 0 | 0 | 0 | For |
| Long Focus Capital Management, LLC | 10,684,233 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 10,559,722 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 10,423,135 | 0 | 0 | 0 | For |
| Rathbones Group PLC | 6,372,000 | 0 | 0 | 0 | For |
| MPM ASSET MANAGEMENT LLC | 5,555,461 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 4,088,112 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 2,425,468 | 0 | 0 | 0 | For |
| Impresa Management LLC | 1,578,783 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 1,485,464 | 0 | 0 | 0 | For |
| Renaissance | 994,628 | 0 | 0 | 0 | For |
| JPMorgan | 855,139 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 715,607 | 0 | 0 | Against |
| Citadel | 584,429 | 0 | 0 | 0 | For |
| Point72 | 373,641 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 341,064 | 0 | 0 | 0 | For |
| Baillie Gifford Investment Management (Europe) Ltd | 321,659 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 266,999 | 0 | 0 | 0 | For |
| BlackRock | 158,706 | 0 | 0 | 0 | For |
| Fidelity | 66,702 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 60,104 | 0 | 0 | Against |
| OPPENHEIMER & CO INC | 0 | 43,532 | 0 | 0 | Against |
| Northern Trust | 42,187 | 0 | 0 | 0 | For |
Institutional-manager reports, all 60 managers: 128,264,033 for, 863,314 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To receive and approve our U.K. statutory directors' remuneration report for the year ended December 31, 2023 (excluding the directors' remuneration policy)
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 11 – Ordinary Resolution to receive and approve the Company's U.K. statutory Directors' remuneration report for the year ended December 31, 2023:”): 995,699,310 for, 43,710,950 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Fund voting reports, all 10 managers: 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 31,124,749 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 12,419,434 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 10,559,722 | 0 | 0 | 0 | For |
| MPM ASSET MANAGEMENT LLC | 5,555,461 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 4,088,112 | 0 | 0 | 0 | For |
| JPMorgan | 855,139 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 715,607 | 0 | 0 | 0 | For |
| Baillie Gifford Investment Management (Europe) Ltd | 321,659 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 266,999 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 60,104 | 0 | 0 | 0 | For |
| OPPENHEIMER & CO INC | 43,532 | 0 | 0 | 0 | For |
| Northern Trust | 42,187 | 0 | 0 | 0 | For |
| BOULDER HILL CAPITAL MANAGEMENT LP | 22,965 | 0 | 0 | 0 | For |
| Atom Investors LP | 10,173 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 7,000 | 0 | 0 | 0 | For |
| Texas Yale Capital Corp. | 3,023 | 0 | 0 | 0 | For |
| D.A. DAVIDSON & CO. | 3,000 | 0 | 0 | 0 | For |
| Chicago Partners Investment Group LLC | 2,904 | 0 | 0 | 0 | For |
| FIDUCIARY TRUST CO | 1,025 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 900 | 0 | 0 | 0 | For |
| BRYN MAWR TRUST Co | 604 | 0 | 0 | 0 | For |
| Calamos | 506 | 0 | 0 | 0 | For |
| Beacon Pointe Advisors, LLC | 60 | 0 | 0 | 0 | For |
| Orion Porfolio Solutions, LLC | 9 | 0 | 0 | 0 | For |
| Orion Portfolio Solutions, LLC | 9 | 0 | 0 | 0 | For |
Institutional-manager reports, all 25 managers: 66,104,883 for.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: To approve our directors' remuneration policy which, if approved, will take effect upon the conclusion of the Annual General Meeting.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 12 – Ordinary Resolution to receive and approve the Company's Directors' remuneration policy, which if approved, will take effect upon conclusion of the Annual General Meeting:”): 987,953,508 for, 50,684,876 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 137,870 | 0 | 0 | Against |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Fund voting reports, all 10 managers: 1,819,477 for, 137,870 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janney Montgomery Scott LLC | 0 | 30,000 | 0 | 0 | Against |
Institutional-manager reports, all 1 managers: 30,000 against.
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit Committee to determine our auditors' remuneration for the fiscal year ending December 31, 2024.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 8 – Ordinary Resolution to authorize the Audit Committee to determine the Company's auditors' remuneration for the fiscal year ending December 31, 2024:”): 1,032,924,716 for, 4,547,610 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To re-appoint KPMG LLP as auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders.
ADAPTIMMUNE THERAPEUTICS PLC’s own tally for this item (“Resolution 7 – Ordinary Resolution to re-appoint KPMG LLP as auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders:”): 1,035,848,288 for, 1,779,828 against, per its Form 8-K filed May 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 10 asset managers below reported 1,957,347 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OLD WESTBURY FUNDS INC | 1,485,464 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 137,870 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 135,565 | 0 | 0 | 0 | For |
| Fidelity | 69,111 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 59,073 | 0 | 0 | 0 | For |
| State Street | 39,929 | 0 | 0 | 0 | For |
| Northern Trust | 20,820 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 7,284 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 1,958 | 0 | 0 | 0 | For |
| Guggenheim | 273 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,533,371,874 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | OLD WESTBURY FUNDS INC | 0.10% |
| 2 | TRUST FOR PROFESSIONAL MANAGERS | <0.01% |
| 3 | HARBOR FUNDS | <0.01% |
| 4 | Fidelity | <0.01% |
| 5 | Harbor ETF Trust | <0.01% |
| 6 | State Street | <0.01% |
| 7 | Northern Trust | <0.01% |
| 8 | BAILLIE GIFFORD FUNDS | <0.01% |
| 9 | MASTER INVESTMENT PORTFOLIO | <0.01% |
| 10 | Guggenheim | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Matrix Capital Management Company, LP | 2.03% |
| 2 | EcoR1 Capital, LLC | 1.79% |
| 3 | BAILLIE GIFFORD & CO LTD | 0.81% |
| 4 | Long Focus Capital Management, LLC | 0.70% |
| 5 | BAKER BROS. ADVISORS LP | 0.69% |
| 6 | PFM Health Sciences, LP | 0.68% |
| 7 | Rathbones Group PLC | 0.42% |
| 8 | MPM ASSET MANAGEMENT LLC | 0.36% |
| 9 | MPM BioImpact LLC | 0.27% |
| 10 | Rock Springs Capital Management LP | 0.16% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Matrix Capital Management Master Fund L.P | 15.25% | DEF14A |
| EcoR1 Capital, LLC | 10.72% | DEF14A |
| Two Seas Capital LP | 8.03% | 13G |
| Ali Behbahani, M.D. | 6.84% | DEF14A |
| Forest Baskett | 6.68% | 13D |
| New Enterprise Associates | 6.68% | DEF14A |
| BAILLIE GIFFORD & CO | 4.62% | 13G |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 1.34% | 13G |
| Adrian Rawcliffe | 1.33% | DEF14A |
| Garry Menzel | 0.93% | DEF14A |
Percentages above are of 1,533,371,874 shares outstanding, as reported by ADAPTIMMUNE THERAPEUTICS PLC on its Form 10-Q dated May 13, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADAPTIMMUNE THERAPEUTICS PLC’s 10-Q dated May 13, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
ADAPTIMMUNE THERAPEUTICS PLC proxy season coverage: 2023-2024 (this page) · 2024-2025.
proxyvotesnow.com, “ADAPTIMMUNE THERAPEUTICS (ADAPY) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/adaptimmune-therapeutics-plc/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.